GlassScriptPhysician profile
Michele Kaplan
NPI 1114562881
$1,689.93
in general payments reported to CMS, 2019-2025
10 companies · $449 in 2025
The $449 reported for 2025 was more than what 89% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $145 · 2023: $414 · 2024: $399 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.81 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Orthodontics Corporation | $371.05 | 2024-2025 | Master Series, Radiance, Empower-Ceramic |
| Align Technology, INC. | $358.41 | 2021-2025 | Itero, Invisalign |
| Ormco Corporation | $207.38 | 2023 | Spark |
| Nobel Biocare USA | $206.55 | 2023 | Nobelactive |
| Envista Holdings Corporation | $188.10 | 2024 | Insignia, Damon, Spark |
| Lightforce Orthodontics, INC. | $131.80 | 2024-2025 | |
| 3m Company | $100.00 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $55.56 | 2022-2024 | Ossix Plus, Arestin |
| Dentsply Sirona INC | $50.54 | 2024-2025 | Mis, Ossix Plus |
| Geistlich Pharma, North America, INC. | $20.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.